Rehydragel®
Aluminum hydroxide technology for appropriate vaccine-adjuvant applications.
View productBioprocess buffers are formulated solutions used to establish or maintain defined pH, concentration and ionic conditions during biopharmaceutical processing and purification.
Controlled operating conditions contribute to repeatable performance across formulation, purification, processing and production. As operations scale, manufacturers may require larger volumes, tailored concentrations and packaging formats that integrate with established workflows.
Aurorium supplies high-purity buffers, salt solutions, sodium hydroxide, potassium hydroxide and USP/WFI water solutions supporting selected biopharmaceutical process requirements. Formulation, manufacturing and packaging capabilities help align concentration, volume, purity specifications and delivery format with customer operations, from development through commercial production.
Potential outcomes
Downstream purification refers to the sequence of separation and purification operations used after biological production to remove process-related impurities and recover the required product.
Material quality, concentration and consistency can influence operating conditions and process reproducibility. Needs vary by modality and workflow, so supporting materials must be evaluated against the specific process.
Aurorium supplies selected high-purity materials and specialty chemistries that support appropriate purification and downstream-processing applications. This includes Reillex™ 425, an ion-exchange resin used in pharmaceutical purification and separation processes for selective impurity removal and chromatographic purification. Product suitability should be evaluated against the specific process requirements of each application.
Potential outcomes
Clean-in-place materials are cleaning chemistries, often including alkaline solutions, used within defined equipment-cleaning procedures without dismantling the process system.
Cleaning operations require materials with appropriate purity, concentration and consistency. Material format and supply reliability also matter because cleaning activities must integrate with manufacturing schedules and facility procedures.
Aurorium provides compendial grade sodium hydroxide and potassium hydroxide in pellet and solution formats for appropriate clean-in-place applications. Manufacturing and packaging flexibility can help customers source high-purity alkaline materials suited to operating requirements.
Potential outcomes
A vaccine adjuvant is a formulation component used with an antigen to support the intended immune response and meet the requirements of the vaccine formulation.
Manufacturers require adjuvant technologies with consistent physical characteristics, reliable characterization and dependable availability. Material consistency becomes increasingly important during scale-up and commercial production.
Aurorium supplies aluminum-based vaccine adjuvant technologies through the Rehydragel® and Rehydraphos® product lines, including aluminum hydroxide and aluminum hydroxyphosphate formulations for appropriate applications.
Potential outcomes
Plasma fractionation is the controlled separation of human plasma into protein fractions that can be further purified for appropriate plasma-derived therapeutic applications.
Materials used within fractionation workflows can influence operational performance and reproducibility. As downstream operations scale, manufacturers evaluate separation materials for process-specific suitability, consistent characteristics and long-term supply reliability.
Aurorium supports selected plasma protein separation and fractionation applications through specialized aluminum hydroxide and hydrogel technologies. Suitability is evaluated against the specific customer process.
Potential outcomes
Aluminum hydroxide technology for appropriate vaccine-adjuvant applications.
View productAluminum hydroxyphosphate adjuvant technology for appropriate vaccine applications.
View productAluminum-based material supporting selected vaccine-formulation and protein plasma separation requirements.
Request InfoAluminum-based adjuvant technology for appropriate formulation requirements.
Request InfoHigh-purity buffer solutions supporting controlled conditions in selected processes.
Request InfoFormulated salt solutions for appropriate process and purification requirements.
Request InfoPellet and solution formats supporting selected processing and clean-in-place applications.
View productIon-exchange resin supporting pharmaceutical purification, separation and impurity-removal applications.
View productBiopharmaceutical applications can require tightly controlled material attributes, formulation knowledge and process-specific technical support.
Explore capabilities
Standard materials may not fully address a formulation, process or handling requirement.
Aurorium evaluates custom derivatives, combinations and specialty compounds within available capabilities.
Material characteristics and process conditions can influence formulation behavior and reproducibility.
Aurorium supports selected adjuvant, buffer and functional-material requirements.
Selected workflows may require specialized functionality or controlled material characteristics.
Aurorium applies chemistry expertise to appropriate specialty-compound and derivative opportunities.
Material choices may affect preparation, handling, integration and scale-up.
Aurorium works with customer teams to understand the application before evaluating options.
Concentration, specification, packaging and volume requirements differ by process and facility.
Aurorium can evaluate tailored formulations and supply programs within available capabilities.
Biopharmaceutical operations require dependable materials, appropriate quality controls and supply arrangements capable of supporting development, scale-up and commercial demand.
Explore capabilities
Regulated applications require defined controls, documentation and consistent execution.
Aurorium offers cGMP-capable manufacturing for suitable products and sites.
Specifications, testing, documentation and change controls help manage material consistency.
Aurorium applies quality systems appropriate to the product, site and application.
Controlled polymer chemistry can enable selected functional materials and custom development.
Aurorium combines relevant process capability with scale-up and manufacturing experience.
Crystallization can influence product consistency, isolation and processability.
Aurorium applies product- and site-specific crystallization capabilities.
Customers may require specific concentrations, specifications, packaging or schedules.
Aurorium evaluates suitable options within product and manufacturing capabilities.
Packaging influences handling, preparation and integration with facility workflows.
Aurorium can evaluate selected single-use or process-compatible formats where available.
Volume, scheduling, inventory and supply planning become increasingly important.
Aurorium combines production capability with customer planning to support appropriate scale and long-term access.
A vaccine adjuvant is a formulation component used with an antigen. A bioprocess buffer is used to establish or maintain controlled process conditions such as pH and ionic strength.
Key considerations can include process-specific suitability, material consistency, concentration, handling, quality requirements and dependable long-term supply.
Aurorium supports appropriate operations with aluminum-based adjuvant technologies, high-purity buffers and salts, alkaline cleaning materials, selected purification support and scalable manufacturing capabilities.